VEL

US IPO Weekly Recap: 3 Chinese companies and a mortgage lender kick off the 2020 US IPO market

Three Chinese issuers and a mortgage lender entered the public market this past week. All four priced below the midpoint. A German issuer and a SPAC submitted initial filings.

Chinese property management company Phoenix Tree Holdings (DNK) priced below the range to raise $130 million (76% from insiders) at a market cap of $2.7 billion. One of the top three apartment rental platforms in China, it is highly unprofitable (-15% gross margin). PhoenixTree finished flat.

Chinese biotech I-Mab Biopharma (IMAB) raised $104 million at a $909 million market cap.  The first Chinese biotech to IPO in the US in over two years and the second largest to IPO in the US ever, I-Mab finished down 11%.

LIZHI (LIZI), the largest user-generated podcast platform in China, raised $45 million (73% indicated on by insiders) at a $503 million market cap.The high growth, unprofitable company has a large market opportunity, and its peers have traded well recently. LIZHI finished up 6%.

Mortgage lender Velocity Financial (VEL) priced below the $14-$16 range to raise $94 million at a $247 million market cap.  The company has high loan yields and grew originations 33% in 2018, but it is highly levered.  Velocity finished up 4%.

4 IPOs During the Week of January 13th, 2020
Issuer
Business
Deal
Size
Market Cap
at IPO
Price vs.
Midpoint
First Day
Return
Return
at 01/17
LIZHI (LIZI) $45M $503M -8% +6% +6%
Chinese interactive podcast platform for user-generated content.
Velocity Financial (VEL) $94M $247M -13% +4% +4%
Mortgage lender focused on residential rental and small commercial properties.
Phoenix Tree Holdings (DNK) $130M $2,711M -13% +0% +0%
Renovates and sub-leases apartments in Chinese cities.
I-Mab Biopharma (IMAB) $104M $909M 4% -11% -11%
Late-stage cancer/autoimmune biotech developing in-licensed antibodies in China.


Sign up for a free trial of our premium platform, IPO Pro. Follow us on Twitter (@IPOtweet) and register for our updates on the IPO market.

 

There were four filings this week. Carlyle-backed German chemicals company Atotech (ATC) filed to raise $100 million though we estimate the deal size may be closer to $1 billion. SPAC East Stone Acquisition (ESSCU) filed to raise $50 million to acquire a fintech business. Cloud-based real estate brokerage Fathom Holdings (FTHM) filed to raise $14 million and biotech Revolution Medicines (RVMD) filed for $100 million.

4 Filings During the Week of January 13th, 2020
Issuer
Business
Deal
Size
Sector Lead
Underwriter
East Stone Acquisition (ESSCU) $100M SPAC I-Bankers
Blank check company formed by East Stone Capital to acquire a fintech business.
Fathom Holdings (FTHM) $14M Real Estate Roth Cap.
Cloud-based full-service real estate brokerage.
Revolution Medicines (RVMD) $100M Health Care JP Morgan
Clinical stage biotech developing novel targeted therapies for cancer.
Atotech (ATC) $1,000M Materials Citi
Carlyle-backed specialty chemicals company carved out of Total.


Sign up for a free trial of our premium platform, IPO Pro. Follow us on Twitter (@IPOtweet) and register for our updates on the IPO market.


In other news, Renaissance Capital released its reports on the top Auditors and the top Law Firms of the 2019 IPO market.

IPO Market Snapshot

The Renaissance IPO Indices are market cap weighted baskets of newly public companies. As of 1/17/20, the Renaissance IPO Index was up 7.5% year-to-date, while the S&P 500 had a gain of 2.66%. Renaissance Capital's IPO ETF (NYSE: IPO) tracks the index, and top ETF holdings include Uber (UBER) and Spotify (SPOT). The Renaissance International IPO Index was up 4.0% year-to-date, while the ACWX was up 1.4%. Renaissance Capital’s International IPO ETF (NYSE: IPOS) tracks
the index, and top ETF holdings include Adyen and Meituan-Dianping.

The article US IPO Weekly Recap: 3 Chinese companies and a mortgage lender kick off the 2020 US IPO market originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.